跳至主要内容
临床试验/NCT03402191
NCT03402191Unknown4 期

Comparative Clinical Study Evaluating the Effect of L-arginine Versus Sildenafil in Children With Beta Thalassemia Associated With Pulmonary Hypertension

Sherief Abd-Elsalam1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2016年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
60
试验地点
1
主要终点
Number of patients with improvement of pulmonary hypertension

研究概览

简要总结

This study compares L-arginine Versus Sildenafil as treatment for pulmonary hypertension in Children with Beta Thalassemia

详细描述

This study focuses on different lines of treatment for pulmonary hypertension in children with thalassemia as this study discusses the Effect of L-arginine Versus Sildenafil in Children with Beta Thalassemia Associated with Pulmonary Hypertension

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
6 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Children with thalassemia and pulmonary hypertension.

排除标准

  • Rheumatic heart diseases.
  • Other comorbid disease

研究组 & 干预措施

L-arginine

Active Comparator

l-arginine for pulmonary hypertension in patients with thalassemia.

干预措施: L-arginine (Drug)

Sildenafil

Active Comparator

Sildenafil for pulmonary hypertension in patients with thalassemia.

干预措施: Sildenafil (Drug)

结局指标

主要结局

Number of patients with improvement of pulmonary hypertension

时间窗: 6 months

patients with improvement of pulmonary hypertension

次要结局

未报告次要终点

研究者

发起方
Sherief Abd-Elsalam
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Sherief Abd-Elsalam

PhDTropical Medicine

Tanta University

研究点 (1)

Loading locations...

相似试验